Tiziana Life Sciences (Tiziana Life Sciences) EV-to-EBITDA : -2.90 (As of May. 11, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Tiziana Life Sciences EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Tiziana Life Sciences's enterprise value is $56.22 Mil. Tiziana Life Sciences's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was $-19.39 Mil. Therefore, Tiziana Life Sciences's EV-to-EBITDA for today is -2.90.

The historical rank and industry rank for Tiziana Life Sciences's EV-to-EBITDA or its related term are showing as below:

TLSA' s EV-to-EBITDA Range Over the Past 10 Years
Min: -18552.26 Med: 0 Max: 10019.99
Current: -2.9

During the past 13 years, the highest EV-to-EBITDA of Tiziana Life Sciences was 10019.99. The lowest was -18552.26. And the median was 0.00.

TLSA's EV-to-EBITDA is ranked worse than
100% of 462 companies
in the Biotechnology industry
Industry Median: 9.49 vs TLSA: -2.90

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-11), Tiziana Life Sciences's stock price is $0.6227. Tiziana Life Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.182. Therefore, Tiziana Life Sciences's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Tiziana Life Sciences EV-to-EBITDA Historical Data

The historical data trend for Tiziana Life Sciences's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tiziana Life Sciences EV-to-EBITDA Chart

Tiziana Life Sciences Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EV-to-EBITDA

Get a 7-Day Free Trial

-9.65

-7.59

-4.61

-2.13

-2.77

Tiziana Life Sciences Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
EV-to-EBITDA	Get a 7-Day Free Trial															-	-2.13	-	-2.77	-

Competitive Comparison of Tiziana Life Sciences's EV-to-EBITDA

For the Biotechnology subindustry, Tiziana Life Sciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tiziana Life Sciences's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tiziana Life Sciences's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Tiziana Life Sciences's EV-to-EBITDA falls into.

Tiziana Life Sciences EV-to-EBITDA Calculation

Tiziana Life Sciences's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	56.218	/	-19.388
	=	-2.90

Tiziana Life Sciences's current Enterprise Value is $56.22 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tiziana Life Sciences's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was $-19.39 Mil.

Tiziana Life Sciences (NAS:TLSA) EV-to-EBITDA Explanation

Tiziana Life Sciences's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	0.6227	/	-0.182
	=	At Loss

Tiziana Life Sciences's share price for today is $0.6227.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tiziana Life Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.182.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Tiziana Life Sciences EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Tiziana Life Sciences's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Tiziana Life Sciences (Tiziana Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tiziana Life Sciences Ltd (NAS:TLSA) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

0RP:Germany

Address

2 Church Street, Clarendon House, Hamilton, BMU, HM 11

Website

https://www.tizianalifesciences.com

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of highly qualified executives with extensive drug development and commercialization experience.